Company · CIK 0001826457 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Monte Rosa Therapeutics, Inc. · GLUE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 SForm 4 → | Jul 17, 4:05 pm EDT | Markus WarmuthPresident & CEO, Director | 9,500 | $23.18 | $220,219 | 585,038 | −1.60% | |
| Jul 15, 2026 SForm 4 → | Jul 16, 4:10 pm EDT | Jennifer ChampouxChief Operating Officer | 4,351 | $23.38 | $101,730 | 62,371 | −6.52% | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 16, 4:10 pm EDT | Jennifer ChampouxChief Operating Officer | 4,351 | $3.98 | $17,317 | 66,722 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 7, 4:41 pm EDT | Sharon TownsonChief Scientific Officer | 6,000 | $23.31 | $139,849 | 67,845 | −8.13% | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 7, 4:41 pm EDT | Sharon TownsonChief Scientific Officer | 6,000 | $6.14 | $36,840 | 73,845 | — | 10b5-1 |
| Jul 1, 2026 JForm 4 → | Jul 6, 5:57 pm EDT | Ali BehbahaniDirector | 1,030,000 | — | — | 0 | — | |
| Jun 30, 2026 SForm 4 → | Jul 1, 4:57 pm EDT | Filip JankuChief Medical Officer | 5,407 | $24.50 | $132,472 | 60,612 | −8.19% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 1, 4:57 pm EDT | Filip JankuChief Medical Officer | 5,407 | $13.41 | $72,508 | 66,019 | — | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 30, 4:05 pm EDT | Filip JankuChief Medical Officer | 6,000 | $22.95 | $137,700 | 59,992 | −9.09% | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jun 30, 4:05 pm EDT | Filip JankuChief Medical Officer | 6,000 | $7.56 | $45,360 | 65,992 | — | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 30, 4:05 pm EDT | Anthony M. ManningDirector | 10,000 | $23.11 | $231,100 | 0 | −100% | |
| Jun 29, 2026 MForm 4 → | Jun 30, 4:05 pm EDT | Anthony M. ManningDirector | 10,000 | $4.16 | $41,600 | 10,000 | — | |
| Jun 23, 2026 SForm 4 → | Jun 25, 4:05 pm EDT | Filip JankuChief Medical Officer | 41,845 | $21.08 | $882,203 | 59,992 | −41.1% | 10b5-1 |
| Jun 23, 2026 MForm 4 → | Jun 25, 4:05 pm EDT | Filip JankuChief Medical Officer | 36,000 | $7.56 | $272,160 | 89,992 | — | 10b5-1 |
| Jun 23, 2026 SForm 4 → | Jun 25, 4:05 pm EDT | Jennifer ChampouxChief Operating Officer | 2,175 | $20.00 | $43,500 | 62,371 | −3.37% | 10b5-1 |
| Jun 23, 2026 MForm 4 → | Jun 25, 4:05 pm EDT | Jennifer ChampouxChief Operating Officer | 2,175 | $3.98 | $8,657 | 64,546 | — | 10b5-1 |
| Jun 23, 2026 SForm 4 → | Jun 25, 4:05 pm EDT | Sharon TownsonChief Scientific Officer | 3,000 | $20.00 | $60,000 | 67,845 | −4.23% | 10b5-1 |
| Jun 23, 2026 MForm 4 → | Jun 25, 4:05 pm EDT | Sharon TownsonChief Scientific Officer | 3,000 | $6.14 | $18,420 | 70,845 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 18, 4:05 pm EDT | Jennifer ChampouxChief Operating Officer | 2,176 | $19.00 | $41,344 | 62,371 | −3.37% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 18, 4:05 pm EDT | Jennifer ChampouxChief Operating Officer | 2,176 | $3.98 | $8,660 | 64,547 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 18, 4:05 pm EDT | Sharon TownsonChief Scientific Officer | 3,000 | $19.00 | $57,000 | 67,845 | −4.23% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 18, 4:05 pm EDT | Sharon TownsonChief Scientific Officer | 3,000 | $6.14 | $18,420 | 70,845 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 MForm 4 → | Jul 16, 4:10 pm EDT | Jennifer ChampouxChief Operating Officer | 4,351 | — | — | 26,947 | — | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 7, 4:41 pm EDT | Sharon TownsonChief Scientific Officer | 6,000 | — | — | 197,290 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 1, 4:57 pm EDT | Filip JankuChief Medical Officer | 5,407 | — | — | 81,093 | — | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jun 30, 4:05 pm EDT | Filip JankuChief Medical Officer | 6,000 | — | — | 60,000 | — | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jun 30, 4:05 pm EDT | Anthony M. ManningDirector | 10,000 | — | — | 2,100 | — | |
| Jun 23, 2026 MForm 4 → | Jun 25, 4:05 pm EDT | Filip JankuChief Medical Officer | 36,000 | — | — | 66,000 | — | 10b5-1 |
| Jun 23, 2026 MForm 4 → | Jun 25, 4:05 pm EDT | Jennifer ChampouxChief Operating Officer | 2,175 | — | — | 31,298 | — | 10b5-1 |
| Jun 23, 2026 MForm 4 → | Jun 25, 4:05 pm EDT | Sharon TownsonChief Scientific Officer | 3,000 | — | — | 203,290 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 18, 4:05 pm EDT | Jennifer ChampouxChief Operating Officer | 2,176 | — | — | 33,473 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 18, 4:05 pm EDT | Sharon TownsonChief Scientific Officer | 3,000 | — | — | 206,290 | — | 10b5-1 |
| Jun 11, 2026 AForm 4 → | Jun 12, 6:44 pm EDT | Ali BehbahaniDirector | 25,800 | — | — | 25,800 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:05 pm EDT | Andrew N SchiffDirector | 25,800 | — | — | 25,800 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:05 pm EDT | Anthony M. ManningDirector | 25,800 | — | — | 25,800 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:05 pm EDT | Jan SkvarkaDirector | 25,800 | — | — | 25,800 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:05 pm EDT | Kimberly BlackwellDirector | 25,800 | — | — | 25,800 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:05 pm EDT | Eric A HughesDirector | 25,800 | — | — | 25,800 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:05 pm EDT | Christine SiuDirector | 25,800 | — | — | 25,800 | — |